Researchers exploit genetic ‘co-dependence’ to kill treatment-resistant tumor cells
Tuesday, October 20, 2009 - 14:21
in Biology & Nature
Cancer cells fueled by the mutant KRAS oncogene, which makes them notoriously difficult to treat, can be killed by blocking a more vulnerable genetic partner of KRAS, report scientists at the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT. read more
Read the whole article on Harvard Science
More from Harvard Science
Related
- Researchers exploit genetic 'co-dependence' to kill treatment-resistant tumor cellsWed, 21 Oct 2009, 13:30:15 EDT
- Massive cancer gene search finds potential new targets in brain tumorsThu, 4 Sep 2008, 14:36:33 EDT
- Childhood brain tumor traced to normal stem cells gone badMon, 11 Aug 2008, 15:21:23 EDT
- Study supports DNA repair-blocker research in cancer therapyMon, 17 Aug 2009, 11:22:47 EDT
- Hitting where it hurts: Exploiting cancer cell 'addiction' may lead to new therapiesMon, 1 Jun 2009, 12:30:56 EDT